Heart Rate Management in Dysautonomic Patients

Introduction to Dysautonomic Tachycardia

The American College of Cardiology, American Heart Association, and Heart Rhythm Society recommend that treatment of inappropriate sinus tachycardia, a related dysautonomic condition, should prioritize symptom relief over lowering the heart rate, as lowering the heart rate may not alleviate symptoms 2
The European Heart Journal suggests lenient rate control targets <110 bpm at rest are appropriate for atrial fibrillation, but this does not apply to dysautonomic tachycardia 1

The American College of Cardiology, American Heart Association, and Heart Rhythm Society state that evaluating and treating reversible causes first is a Class I recommendation for inappropriate sinus tachycardia, before attempting rate control 2
Beta blockers may be considered (Class IIb) for symptomatic patients, though they are often ineffective or poorly tolerated due to cardiovascular side effects like hypotension 2
Ivabradine is reasonable (Class IIa) for ongoing management in symptomatic patients, as it selectively reduces heart rate without other hemodynamic effects 2
Combination therapy with beta blockers and ivabradine may be considered (Class IIb) when monotherapy is insufficient 2

When cardiac function is poor, cardiac output can be dependent on a rapid heart rate, so "normalizing" the heart rate can be detrimental, particularly in dysautonomic patients where the tachycardia may be maintaining adequate perfusion 3, 4
Heart rates <150 bpm are unlikely to cause hemodynamic instability unless ventricular dysfunction is present, and therefore aggressive rate control is not indicated in stable dysautonomic patients with resting tachycardia below this threshold 3, 4, 5

Exercise training may provide benefit, though the evidence is limited, according to the American Heart Association 2
The European Heart Journal and the Journal of the American College of Cardiology advise against applying standard rate control targets from atrial fibrillation guidelines to dysautonomic patients 1, 6, 7
The American College of Cardiology, American Heart Association, and Heart Rhythm Society recommend avoiding aggressive treatment of asymptomatic tachycardia, as the prognosis is generally benign, and avoiding medications that may worsen orthostatic symptoms or cause hypotension 2